


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
PGNY
Progyny
$26.43
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value
Chart
$19.23 (+37.44%)
$23.67 (+11.66%)
$21.46 (+23.16%)
$14.76 (+79.07%)
PGNY has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

PGNY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
PGNY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PGNY Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is PGNY current stock price?
What are PGNY stock strengths?
What is PGNY Risk Level?
What is PGNY market cap and volume?
What is PGNY current Stock IQ?
Should I buy PGNY stock right now?
Is PGNY a Strong Buy right now?
What does a 'Strong Buy' rating mean for PGNY?
What does a 'Strong Sell' rating mean for PGNY?
What factors influence PGNY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+5.41%
+0.27%
+0.81%
+3.85%
PGNY
Progyny
Current Price
$26.43
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Chart
$19.23 (+37.44%)
$23.67 (+11.66%)
$21.46 (+23.16%)
$14.76 (+79.07%)
PGNY Analysts Opinion
PGNY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
PGNY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PGNY Street Sentiment is extremely bullish and have positive views on the near-term outlook
PGNY has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
PGNY Latest Analysis
Norman Payson At Progyny Executes Options Exercise Realizing $876K. A substantial insider activity was disclosed on November 18 as Payson Director at ) reported the exercise of a large sell of company stock options.United States Securities and Exchange Commission on Tuesday showed that Payson Director at Progyny a company in the Health Care sector just exercised stock options worth 36224 shares of PGNY stock with an exercise price of $1.45.The Wednesday morning market activity shows Progyny Inc
Wed Nov 19, 2025
Progyny Inc. (PGNY) Hit a 52 Week High Can the Run Continue?. Progyny (PGNY) is at a 52-week high but can investors hope for more gains in the future? We take a look at the companys fundamentals for clues.
Tue Nov 18, 2025
Canaccord Genuity Maintains Progyny (PGNY) Hold Recommendation. Fintel reports that on November 17 2025 Canaccord Genuity maintained coverage of Progyny (NasdaqGS:PGNY) with a Hold recommendation. Analyst Price Forecast Suggests 9.43% Upside
Tue Nov 18, 2025
Monday 11/17 Insider Buying Report: PGNY VAC. As the saying goes there are many possible reasons for an insider to sell a stock but only one reason to buy -- they expect to make money. So lets look at two noteworthy recent insider buys.At Progyny a filing with the SEC revealed that on Thursday CHIEF EXECUTIVE OFFICE
Mon Nov 17, 2025
Eye On Growth: Peter Anevski Adds $1.93M Of Progyny Stock To Portfolio. On November 17 ) executed a significant insider buy as disclosed in the latest SEC filing.United States Securities and Exchange Commission on Monday showed that Anevski purchased 79500 shares of Progyny. The total transaction amounted to $1930896. In the Monday'.s morning session Progyny Inc is a benefits management company specializing in fertility family building and women'.s health benefits solutions. Its clients
Mon Nov 17, 2025
Progyny CEO buys $1.93M in company stock.
Mon Nov 17, 2025
Progyny Inc. to Present at Jefferies Global Healthcare Conference. NEW YORK Nov. 13 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY) a global leader in womens health and family building solutions today announced that Mark Livingston Progynys Chief Financial Officer will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday November 18 2025 at 3:00 p.m. GMT / 10:00 a.m. ET.
Thu Nov 13, 2025
Keybanc Upgrades Progyny (PGNY). Fintel reports that on November 12 2025 Keybanc upgraded their outlook for Progyny (NasdaqGS:PGNY) from Sector Weight to Overweight. Analyst Price Forecast Suggests 21.63% Upside
Thu Nov 13, 2025
Progyny upgraded at KeyBanc on catalysts over next year.
Wed Nov 12, 2025
JP Morgan Maintains Progyny (PGNY) Neutral Recommendation. Fintel reports that on November 11 2025 JP Morgan maintained coverage of Progyny (NasdaqGS:PGNY) with a Neutral recommendation. Analyst Price Forecast Suggests 23.01% Upside
Wed Nov 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PGNY Stock trends
PGNY Stock performance
PGNY Stock analysis
PGNY investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.